Issue 3/2009
Content (16 Articles)
Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to γ-radiation
Anne Katrin Schauff, Ella L. Kim, Jan Leppert, Roger Nadrowitz, Robin Wuestenberg, Mark Alexander Brockmann, Alf Giese
Genetic characterization of adult infratentorial gliomas
Tomoru Miwa, Yuichi Hirose, Hikaru Sasaki, Eiji Ikeda, Kazunari Yoshida, Takeshi Kawase
DNA alkylation products formed by 1-(2-chloroethyl)-1-nitrosourea as molecular dosimeters of therapeutic response
William J. Bodell
A role for the p53 pathway in the pathology of meningiomas with NF2 loss
ZeNan Chang, Chin-Lin Guo, Iris Ahronowitz, Anat O. Stemmer-Rachamimov, Mia MacCollin, Fabio P. Nunes
Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C
Marc C. Chamberlain, Sandra K. Johnston, Alixis Van Horn, Michael J. Glantz
Histone acetylation resulting in resistance to methotrexate in choroid plexus cells
Preethi Prasad, Hernan Vasquez, Chandra M. Das, Vidya Gopalakrishnan, Johannes E. A. Wolff
Modeling the effects of resection, radiation and chemotherapy in glioblastoma
Jianjun Paul Tian, Avner Friedman, Jin Wang, E. Antonio Chiocca
Molecular detection of human mammaglobin in cerebrospinal fluid from breast cancer patient with leptomeningeal carcinomatosis
Mariella Dono, Paola Ferro, Luana Benedetti, Cesare Capellini, Michele Moroni, Paolo Dessanti, Bartolomeo Bacigalupo, Antonio Tartaglione, Enrico Battolla, Franco Fedeli, Silvio Roncella
Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study
Hendrik Pels, Annika Juergens, Axel Glasmacher, Holger Schulz, Andreas Engert, Michael Linnebank, Gabriele Schackert, Heinz Reichmann, Frank Kroschinsky, Marlies Vogt-Schaden, Gerlinde Egerer, Udo Bode, Carlo Schaller, Monika Lamprecht, Peter Hau, Martina Deckert, Rolf Fimmers, Christopher Bangard, Ingo G. H. Schmidt-Wolf, Uwe Schlegel
Brain metastases from hepatocellular carcinoma: prognostic factors and outcome
Hye Jin Choi, Byung Chul Cho, Joo Hyuk Sohn, Sang Jun Shin, Se Hyun Kim, Joo Hang Kim, Nae Choon Yoo
Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy
Denise D. Correa, Mary Rocco-Donovan, Lisa M. DeAngelis, Rima Dolgoff-Kaspar, Fabio Iwamoto, Joachim Yahalom, Lauren E. Abrey
WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options
Toba N. Niazi, Elizabeth M. Jensen, Randy L. Jensen
Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan
R. M. Zuniga, R. Torcuator, R. Jain, J. Anderson, T. Doyle, S. Ellika, L. Schultz, T. Mikkelsen
Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM
Forrest W. Crawford, Inas S. Khayal, Colleen McGue, Suja Saraswathy, Andrea Pirzkall, Soonmee Cha, Kathleen R. Lamborn, Susan M. Chang, Mitchel S. Berger, Sarah J. Nelson
Nuclear survivin expression predicts poorer prognosis in glioblastoma
Katsuyuki Shirai, Yoshiyuki Suzuki, Kuniyuki Oka, Shin-ei Noda, Hiroyuki Katoh, Yoshihiko Suzuki, Jun Itoh, Hideaki Itoh, Shogo Ishiuchi, Hideyuki Sakurai, Masatoshi Hasegawa, Takashi Nakano
Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma
Marc C. Chamberlain, Sandra Johnston